Results 161 to 170 of about 600,045 (285)

The humanised CYP2C19 transgenic mouse exhibits cerebellar atrophy and movement impairment reminiscent of ataxia. [PDF]

open access: yesNeuropathol Appl Neurobiol, 2023
Milosavljević F   +15 more
europepmc   +1 more source

Data‐Driven Insights into Hyperkinetic Disorders in Neurodevelopmental Syndromes and Epileptic Encephalopathies

open access: yesMovement Disorders Clinical Practice, EarlyView.
Abstract Background Childhood‐onset hyperkinetic movement disorders occur in a range of genetic conditions. Recently, there has been an increase in recognition of hyperkinetic movement disorders, mainly dystonia, chorea and dyskinesia, with monogenic conditions associated with neurodevelopmental delay (NDD) and also with developmental and epileptic ...
Hugo Morales‐Briceño   +6 more
wiley   +1 more source

A Novel RORA Hinge-Region Variant in Adult IDDECA With Cerebellar Atrophy and Marked Response to Valproate. [PDF]

open access: yesEur J Neurol
Busco V   +6 more
europepmc   +1 more source

Cerebellar atrophy and its implications on gait in cerebral amyloid angiopathy. [PDF]

open access: yesJ Neurol Neurosurg Psychiatry, 2022
Horn MJ   +13 more
europepmc   +1 more source

Breathe, Eat, Talk: Three Essential Ingredients to Quality‐of‐Life Outcomes in Movement Disorders

open access: yesMovement Disorders Clinical Practice, EarlyView.
Abstract Background Breathing, eating, and talking (BET) impairments are common yet frequently underrecognized features of movement disorders. Deficits in respiration, swallowing, voice, and speech may emerge early in the course of a disease, adversely affecting safety, participation, and quality of life.
John Dean   +16 more
wiley   +1 more source

Genetic Etiologies of Dystonia with Anarthria/Aphonia

open access: yesMovement Disorders Clinical Practice, EarlyView.
Abstract Background Dystonia with anarthria and/or aphonia (DAnAp) represents a distinctive phenotype manifesting across lifespan. Frequently associated with genetic disorders, early recognition is critical for diagnosis and management. Objectives To provide practical recommendations for the clinical evaluation of patients with DAnAp, enhancing ...
Anika Ménétrey   +7 more
wiley   +1 more source

Indentification of novel MSTO1 compound heterozygous mutations in a Chinese family with recessive cerebellar atrophy and ataxia. [PDF]

open access: yesFront Neurol, 2022
Chen J   +11 more
europepmc   +1 more source

Cerebellar atrophy in Parkinson's disease and its implication for network connectivity.

open access: yesBrain : a journal of neurology, 2016
C. O’Callaghan   +5 more
semanticscholar   +1 more source

Progressive cerebellar atrophy caused by heterozygous TECPR2 mutations. [PDF]

open access: yesMol Genet Genomic Med, 2022
Ramsey K   +10 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy